Raven-Symoné recalls being pushed to alter her body in order to get a television show at the tender age of 15.

SamanTree Medical, a leader in oncologic surgical imaging innovation, today announced promising results from the SHIELD study ...

Avril Mathie - who has clocked up a record of 8-1-1 since switching to the fight game after winning the Miss Swimsuit USA crown - believes the cosmetic procedure will pay off in the ring.

While under competitive pressure from Novartis and Eli Lilly, Pfizer can tally up a unique trial win for its Ibrance in a ...

The 38-year-old actress - who started out as a child on 'The Cosby Show' and then found worldwide fame when she took on the title role of the Disney Channel sitcom 'That's So Raven' - revealed that ...

The benefit of the PARP inhibitor in patients with germline BRCA pathogenic variants remains evident 10 years after the first ...

The findings from the study demonstrated a substantial decrease in reoperation rates when the Histolog scanner was utilised.

AstraZeneca and MSD's PARP inhibitor Lynparza has improved long-term survival when given as adjuvant therapy for early breast ...

Receiving immediate surgery was associated with a reduction in local recurrence of breast cancer in elderly patients versus delaying surgery.

Interim overall survival (OS) analyses at 31% maturity in patients with ESR1 mutations, and 23% maturity among all patients, ...

Adjuvant olaparib continued to show a strong efficacy benefit in patients with BRCA1/2 mutation–positive, HER2-negative ...

Adjuvant Lynparza remains beneficial for patients with BRCA1/2 mutation–positive, HER2-negative high-risk breast cancer, study results have shown.